222 related articles for article (PubMed ID: 28729175)
1. Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion.
Abdou EM; Kandil SM; Miniawy HMFE
Int J Pharm; 2017 Aug; 529(1-2):667-677. PubMed ID: 28729175
[TBL] [Abstract][Full Text] [Related]
2. Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency.
Abd-Elal RM; Shamma RN; Rashed HM; Bendas ER
Drug Deliv; 2016 Nov; 23(9):3374-3386. PubMed ID: 27128792
[TBL] [Abstract][Full Text] [Related]
3. Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting.
Gavini E; Rassu G; Ferraro L; Beggiato S; Alhalaweh A; Velaga S; Marchetti N; Bandiera P; Giunchedi P; Dalpiaz A
Eur J Pharm Biopharm; 2013 Feb; 83(2):174-83. PubMed ID: 23153670
[TBL] [Abstract][Full Text] [Related]
4. Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies.
Shelke S; Shahi S; Jalalpure S; Dhamecha D
J Liposome Res; 2016 Dec; 26(4):313-23. PubMed ID: 26758957
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic study and brain tissue analysis of Zolmitriptan loaded chitosan nanoparticles in rats by LC-MS method.
Khezri FANZ; Lakshmi CSR; Bukka R; Nidhi M; Nargund SL
Int J Biol Macromol; 2020 Jan; 142():52-62. PubMed ID: 31593739
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Brain Targeting Potential of Zolmitriptan Mucoadhesive Nanoparticles for Intranasal Drug Delivery.
Jha S; Mishra D
Pharm Nanotechnol; 2022; 10(2):113-124. PubMed ID: 35240970
[TBL] [Abstract][Full Text] [Related]
7. Optimization of combinational intranasal drug delivery system for the management of migraine by using statistical design.
Kumar A; Garg T; Sarma GS; Rath G; Goyal AK
Eur J Pharm Sci; 2015 Apr; 70():140-51. PubMed ID: 25676136
[TBL] [Abstract][Full Text] [Related]
8. Development of zolmitriptan transfersomes by Box-Behnken design for nasal delivery: in vitro and in vivo evaluation.
Pitta SK; Dudhipala N; Narala A; Veerabrahma K
Drug Dev Ind Pharm; 2018 Mar; 44(3):484-492. PubMed ID: 29124986
[TBL] [Abstract][Full Text] [Related]
9. Intranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain-targeting.
Vyas TK; Babbar AK; Sharma RK; Misra A
J Drug Target; 2005 Jun; 13(5):317-24. PubMed ID: 16199375
[TBL] [Abstract][Full Text] [Related]
10. Formulation and evaluation of chitosan-chondroitin sulphate based nasal inserts for zolmitriptan.
Kaur K; Kaur G
Biomed Res Int; 2013; 2013():958465. PubMed ID: 24175310
[TBL] [Abstract][Full Text] [Related]
11. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of submicron emulsion as vehicles for rapid-onset intranasal delivery and improvement in brain targeting of zolmitriptan.
Yu C; Gu P; Zhang W; Cai C; He H; Tang X
Drug Deliv; 2011 Nov; 18(8):578-85. PubMed ID: 21838542
[TBL] [Abstract][Full Text] [Related]
13. A coupled bimodal SPECT-CT imaging and brain kinetics studies of zolmitriptan-encapsulated nanostructured polymeric carriers.
Mandlik SK; Ranpise NS; Mohanty BS; Chaudhari PR
Drug Deliv Transl Res; 2018 Jun; 8(3):797-805. PubMed ID: 29380155
[TBL] [Abstract][Full Text] [Related]
14. Zolmitriptan Nasal Spray: A Review in Acute Migraine in Pediatric Patients 12 Years of Age or Older.
McKeage K
Paediatr Drugs; 2016 Feb; 18(1):75-81. PubMed ID: 26747634
[TBL] [Abstract][Full Text] [Related]
15. Intranasal zolmitriptan.
Gawel M; Worthington I
Expert Opin Pharmacother; 2005 Jun; 6(6):1019-24. PubMed ID: 15952929
[TBL] [Abstract][Full Text] [Related]
16. Rheological evaluation of thermoreversible and mucoadhesive nasal gels of Zolmitriptan.
Kumari A; Sharma N; Sharma PK; Goyal N
Eur Rev Med Pharmacol Sci; 2012 Aug; 16(8):1022-7. PubMed ID: 22913151
[TBL] [Abstract][Full Text] [Related]
17. Preparation of zolmitriptan-chitosan microparticles by spray drying for nasal delivery.
Alhalaweh A; Andersson S; Velaga SP
Eur J Pharm Sci; 2009 Oct; 38(3):206-14. PubMed ID: 19616094
[TBL] [Abstract][Full Text] [Related]
18. In-vitro and in-vivo respiratory deposition of a developed metered dose inhaler formulation of an anti-migraine drug.
Abdou EM; Kandil SM; Morsi A; Sleem MW
Drug Deliv; 2019 Dec; 26(1):689-699. PubMed ID: 31274014
[TBL] [Abstract][Full Text] [Related]
19. Intranasal zolmitriptan for the treatment of acute migraine.
Tepper SJ; Chen S; Reidenbach F; Rapoport AM
Headache; 2013 Sep; 53 Suppl 2():62-71. PubMed ID: 24024604
[TBL] [Abstract][Full Text] [Related]
20. Zolmitriptan intranasal: a review of the pharmacokinetics and clinical efficacy.
Goadsby PJ; Yates R
Headache; 2006 Jan; 46(1):138-49. PubMed ID: 16412161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
